Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 857109, 9 pages
http://dx.doi.org/10.1155/2014/857109
Research Article

Role of Ethyl Pyruvate in Systemic Inflammatory Response and Lung Injury in an Experimental Model of Ruptured Abdominal Aortic Aneurysm

1Department of Cardiovascular Surgery, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, Turkey
2Depertment of Biochemistry, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, Turkey
3Depertment of Histology and Embryology, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, Turkey

Received 31 October 2013; Accepted 7 December 2013; Published 19 January 2014

Academic Editor: Ahmet Eroglu

Copyright © 2014 Zerrin Pulathan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Mehta, J. Byrne, and J. Taggert, “Endovascular aneurysm repair as a mean of treatment for ruptured abdominal aortic aneurysms,” Chinese Medical Journal, vol. 126, no. 3, pp. 546–553, 2013. View at Google Scholar
  2. T. F. Lindsay, P. Walker, and A. Romaschin, “Acute pulmonary injury in a model of ruptured abdominal aortic aneurysm,” Journal of Vascular Surgery, vol. 22, no. 1, pp. 1–8, 1995. View at Publisher · View at Google Scholar · View at Scopus
  3. M. H. Eslami and L. M. Messina, “Ruptured AAA: open surgical management,” Seminars in Vascular Surgery, vol. 23, no. 4, pp. 200–205, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. B.-Q. Cheng, C.-T. Liu, W.-J. Li et al., “Ethyl pyruvate improves survival and ameliorates distant organ injury in rats with severe acute pancreatitis,” Pancreas, vol. 35, no. 3, pp. 256–261, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. M. P. Fink, “Ethyl pyruvate: a novel treatment for sepsis and shock,” Minerva Anestesiologica, vol. 70, no. 5, pp. 365–371, 2004. View at Google Scholar · View at Scopus
  6. T. Uchiyama, R. L. Delude, and M. P. Fink, “Dose-dependent effects of ethyl pyruvate in mice subjected to mesenteric ischemia and reperfusion,” Intensive Care Medicine, vol. 29, no. 11, pp. 2050–2058, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. M. P. Fink, “Ethyl pyruvate: a novel anti-inflammatory agent,” Journal of Internal Medicine, vol. 261, no. 4, pp. 349–362, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Uchiyama and M. Mihara, “Determination of malonaldehyde precursor in tissues by thiobarbituric acid test,” Analytical Biochemistry, vol. 86, no. 1, pp. 271–278, 1978. View at Google Scholar · View at Scopus
  9. K. Yagi, “Assay for blood plasma or serum,” Methods in Enzymology, vol. 105, pp. 328–331, 1984. View at Google Scholar · View at Scopus
  10. L. Yang, R. M. Froio, T. E. Sciuto, A. M. Dvorak, R. Alon, and F. W. Luscinskas, “ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-α-activated vascular endothelium under flow,” Blood, vol. 106, no. 2, pp. 584–592, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Bar-Or, G. Curtis, N. Rao, N. Bampos, and E. Lau, “Characterization of the Co2+ and Ni2+ binding amino-acid residues of the N-terminus of human albumin: an insight into the mechanism of a new assay for myocardial ischemia,” European Journal of Biochemistry, vol. 268, no. 1, pp. 42–47, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Uchiyama and M. Mihara, “Determination of malonaldehyde precursor in tissues by thiobarbituric acid test,” Analytical Biochemistry, vol. 86, no. 1, pp. 271–278, 1978. View at Google Scholar · View at Scopus
  13. C. Tekinbas, H. Ulusoy, E. Yulug et al., “One-lung ventilation: for how long?” Journal of Thoracic and Cardiovascular Surgery, vol. 134, no. 2, pp. 405–410, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. M. J. Bown, M. L. Nicholson, P. R. F. Bell, and R. D. Sayers, “The systemic inflammatory response syndrome, organ failure, and mortality after abdominal aortic aneurysm repair,” Journal of Vascular Surgery, vol. 37, no. 3, pp. 600–606, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. R. J. Cruz Jr., T. Harada, E. Sasatomi, and M. P. Fink, “Effects of ethyl pyruvate and other α-keto carboxylic acid derivatives in a rat model of multivisceral ischemia and reperfusion,” Journal of Surgical Research, vol. 165, no. 1, pp. 151–157, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. R. S. Crawford, H. Albadawi, M. D. Atkins et al., “Postischemic treatment with ethyl pyruvate prevents adenosine triphosphate depletion, ameliorates inflammation, and decreases thrombosis in a murine model of hind-limb ischemia and reperfusion,” Journal of Trauma, vol. 70, no. 1, pp. 103–110, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. W.-C. Jan, C.-H. Chen, P.-S. Tsai, and C.-J. Huang, “Limb ischemic preconditioning mitigates lung injury induced by haemorrhagic shock/resuscitation in rats,” Resuscitation, vol. 82, no. 6, pp. 760–766, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. M. D. Taylor, T. J. Grand, J. E. Cohen et al., “Ethyl pyruvate enhances ATP levels, reduces oxidative stress and preserves cardiac function in a rat model of off-pump coronary bypass,” Heart Lung and Circulation, vol. 14, no. 1, pp. 25–31, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Wang, G. Gong, Z. Wei, and Y. Li, “Ethyl pyruvate prevents intestinal inflammatory response and oxidative stress in a rat model of extrahepatic cholestasis,” Journal of Surgical Research, vol. 160, no. 2, pp. 228–235, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. Z.-G. Luan, H. Zhang, X.-C. Ma, C. Zhang, and R.-X. Guo, “Role of high-mobility group box 1 protein in the pathogenesis of intestinal barrier injury in rats with severe acute pancreatitis,” Pancreas, vol. 39, no. 2, pp. 216–223, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Cai, E. A. Deitch, D. Grande, and L. Ulloa, “Anti-inflammatory resuscitation improves survival in hemorrhage with trauma,” Journal of Trauma, vol. 66, no. 6, pp. 1632–1639, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. C.-W. Kung, Y.-M. Lee, P.-Y. Cheng, Y.-J. Peng, and M.-H. Yen, “Ethyl pyruvate reduces acute lung injury via regulation of iNOS and HO-1 expression in endotoxemic rats,” Journal of Surgical Research, vol. 167, no. 2, pp. e323–e331, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Shahani, J. G. Marshall, B. B. Rubin, R.-K. Li, P. M. Walker, and T. F. Lindsay, “Role of TNF-α in myocardial dysfunction after hemorrhagic shock and lower-torso ischemia,” American Journal of Physiology, vol. 278, no. 3, pp. H942–H950, 2000. View at Google Scholar · View at Scopus
  24. D. W. Harkin, C. D. Marron, R. P. Rother, A. Romaschin, B. B. Rubin, and T. F. Lindsay, “C5 complement inhibition attenuates shock and acute lung injury in an experimental model of ruptured abdominal aortic aneurysm,” British Journal of Surgery, vol. 92, no. 10, pp. 1227–1234, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Swartbol, L. Truedsson, and L. Norgren, “The inflammatory response and its consequence for the clinical outcome following aortic aneurysm repair,” European Journal of Vascular and Endovascular Surgery, vol. 21, no. 5, pp. 393–400, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. E. Sbarouni, P. Georgiadou, and V. Voudris, “Ischemia modified albumin changes—review and clinical implications,” Clinical Chemistry and Laboratory Medicine, vol. 49, no. 2, pp. 177–184, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Zhong, N. Wang, H. Xu, X. Hou, P. Xu, and Z. Zhou, “Ischemia-modified albumin in stable coronary atherosclerotic heart disease: clinical diagnosis and risk stratification,” Coronary Artery Disease, vol. 23, no. 8, pp. 538–541, 2012. View at Google Scholar
  28. S. Turedi, A. Gunduz, A. Mentese et al., “Investigation of the possibility of using ischemia-modified albumin as a novel and early prognostic marker in cardiac arrest patients after cardiopulmonary resuscitation,” Resuscitation, vol. 80, no. 9, pp. 994–999, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Gunduz, S. Turkmen, S. Turedi et al., “Time-dependent variations in ischemia-modified albumin levels in mesenteric ischemia,” Academic Emergency Medicine, vol. 16, no. 6, pp. 539–543, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. B.-Q. Cheng, C.-T. Liu, W.-J. Li et al., “Ethyl pyruvate improves survival and ameliorates distant organ injury in rats with severe acute pancreatitis,” Pancreas, vol. 35, no. 3, pp. 256–261, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. M. P. Fink, “Reactive oxygen species as mediators of organ dysfunction caused by sepsis, acute respiratory distress syndrome, or hemorrhagic shock: potential benefits of resuscitation with Ringer's ethyl pyruvate solution,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 5, no. 2, pp. 167–174, 2002. View at Google Scholar · View at Scopus
  32. M. Karabeyoglu, B. Kocer, U. Ozel et al., “The protective effect of ethyl pyruvate on lung injury after burn in rats,” Saudi Medical Journal, vol. 28, no. 10, pp. 1489–1492, 2007. View at Google Scholar · View at Scopus
  33. Z. S. Tawadrous, R. L. Delude, and M. P. Fink, “Resuscitation from hemorrhagic shock with ringer's ethyl pyruvate solution improves survival and ameliorates intestinal mucosal hyperpermeability in rats,” Shock, vol. 17, no. 6, pp. 473–477, 2002. View at Google Scholar · View at Scopus